Zobrazeno 1 - 9
of 9
pro vyhledávání: '"John Robert Adair"'
Publikováno v:
Expert Opinion on Investigational Drugs. 8:211-227
The production of recombinant proteins in plants is reviewed with a particular focus on plant-derived vaccines and antibodies for human healthcare. Issues relating to foreign gene expression, such as protein yield, localisation and glycosylation are
Publikováno v:
Expert Opinion on Investigational Drugs. 4:863-870
(1995). Monthly Update: Biologicals & Immunologicals: Progress with humanised antibodies - An update. Expert Opinion on Investigational Drugs: Vol. 4, No. 9, pp. 863-870.
Autor:
Geoffrey Yarranton, David J. King, Nigel Richard Whittle, Andrew Millican, John Robert Adair, Raymond J. Owens, Alan Howard Lyons
Publikováno v:
"Protein Engineering, Design and Selection". 3:703-708
Many diagnostic and therapeutic applications of monoclonal antibodies require the covalent linking of effector or reporter molecules to the immunoglobulin polypeptides. Existing methods generally involve the non-selective modification of amino acid s
Autor:
M. R. Rolfe, John Robert Adair, D. J. King, Raymond J. Owens, H. M. Caskey-Finney, Andrew Mountain, M. Sehdev, T. S. Baker, C. C. Bose, Alan Howard Lyons, Alastair D. G. Lawson, G. T. Yarranton
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781461360384
Antibody-drug conjugates utilize the targetting potential of antibodies to improve the potential of cytostatic or cytocidal drugs. One such murine monoclonal antibody, CTM01 (mCTM0l), which recognizes an epitope on breast epithelial mucin, has potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c06ce4900bf08093018381e5f38de67
https://doi.org/10.1007/978-1-4615-2443-4_8
https://doi.org/10.1007/978-1-4615-2443-4_8
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
Autor:
John Robert Adair, B. Pedley, Sarojani Angal, Mark Bodmer, David J. King, A. Turner, Alastair David Griffiths Lawson, G. Roberts
Publikováno v:
Molecular immunology. 30(1)
Human immunoglobulin G4 (IgG4) exists in two molecular forms due to the heterogeneity of the inter-heavy chain disulphide bridges in the hinge region in a proportion of secreted human IgG4. This heterogeneity is only revealed under denaturing, non-re
Autor:
D C Low, John Robert Adair, Geoffrey Yarranton, Sarojani Angal, K A Proudfoot, J. C. Lloyd, David J. King, Mark Bodmer
Publikováno v:
The Biochemical journal. 281
B72.3 is a mouse monoclonal antibody against a tumour-associated antigen, TAG72, which recognizes breast, ovarian and colorectal tumour tissue. A mouse-human chimeric version of B72.3 has been expressed in Chinese-hamster ovary cells. This molecule h
Publikováno v:
Immunology today. 12(4)
Access to a wide range of high quality and increasingly sophisticated reagents and equipment has underpinned the great surge of knowledge in basic immunology and the growing interest in clinical immunointervention. In this article, the first in an oc
Autor:
D. J. King, G. T. Yarranton, P. Antoniw, A. Turner, Alan Howard Lyons, S. Welt, Helene Margaret Finney, D. Shochat, Raymond J. Owens, Alastair D. G. Lawson, A P Farnsworth, L. J. Old, A. M. R. Haines, John Robert Adair
Publikováno v:
Journal of Immunotherapy. 16:156
Autor:
David Colcher, Mark Bodmer, Liz Jenkins, John Robert Adair, Andrew Raubitschek, Jeffrey Schlom, Nigel Richard Whittle, Joan Devine, Chris Lloyd
Publikováno v:
"Protein Engineering, Design and Selection". 1:499-505
B72.3 is a mouse hybridoma cell-line secreting an IgG1 antibody which recognises an epitope on a tumour-associated antigen, TAG-72. This high molecular weight mucin-like molecule is found on a variety of human neoplasms, including colon, breast and o